Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence

INTRODUCTION: The goal of chronic hepatitis C (CHC) treatment is to achieve a sustained virologic response (SVR). The new generation of direct-acting antivirals (DAAs) offers 90–100% SVR rates. However, access to these treatments is generally limited to patients with advanced liver disease. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuño Solinís, Roberto, Arratibel Ugarte, Patricia, Rojo, Ander, Sanchez Gonzalez, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125137/
https://www.ncbi.nlm.nih.gov/pubmed/27783223
http://dx.doi.org/10.1007/s40121-016-0134-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125137/
https://www.ncbi.nlm.nih.gov/pubmed/27783223
http://dx.doi.org/10.1007/s40121-016-0134-x

Ejemplares similares